Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Dexamethasone may influence hair growth by altering estrogen receptor activity in hair cells.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Estrogen deficiency, like after menopause or certain surgeries, leads to faster skin aging and health issues.

Excess androgens may cause PCOS, not just be a symptom.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

SHBG may be a useful early indicator and treatment target for PCOS.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.